Pelvic Floor Diagnostics Market
Market Insights on Pelvic Floor Diagnostics covering sales outlook, demand forecast & up-to-date key trends
Pelvic Floor Diagnostics Market by Product (Urodynamics Systems, Uroflowmetry Devices, Anal Manometry Systems, Cystoscopes, Ultrasound Systems, EMG), End User (Hospitals, Diagnostic Imaging Centers, Specialty Clinics) & Region - Forecast to 2021-2031
Pelvic Floor Diagnostics Market Snapshot
[250 Pages Report] As per newly released data by Future Market Insights Market, the global demand for l pelvic floor diagnostics market will increase at a year-on-year (YoY) growth of 7.0% in 2021.
Overall valuation of the pelvic floor diagnostics market will total US$ 1,823.6 Mn for 2021, and it is expected to rise at a 6.2% CAGR through the end of the assessment period in 2031.
The report also forecasts the demand for uroflowmetry devices and anal manometry systems are expected to rise at 8.2% CAGR through the assessment period.
Let us know your requirement to get
100% FREE customization
Key Points Covered in the Pelvic Floor Diagnostics Market
- Market estimates and forecast 2016-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Pelvic Floor Diagnostics and How to Navigate
- Recommendation on Key Winning Strategies
2016-2020 Pelvic Floor Diagnostics Market Outlook Compared to 2021-2031 Forecast
The pelvic floor diagnostics market is expected to rise at a CAGR of 6.2% between 2021 and 2031 in comparison to the 3.5% CAGR registered during 2016-2020. This growth is highly associated with factors such as growing healthcare expenditure and the rising number of technology advancements in the pelvic floor diagnostic sectors.
The prevalence of pelvic floor disorders especially among pregnant women and growing awareness for early diagnosis have further propelled sales of pelvic floor diagnostics systems. Growing research and development activities in the field have been supported by financial grants through key players and have led to innovative breakthroughs in disease control.
Rising awareness among women and men about early diagnosis has led to increased set up of diagnostic imaging centers. There is a surge in demand for ultrasound imaging systems for high-resolution imaging over the radiological methods.
The rise in healthcare spending and growing funding associated with favorable reimbursement has led manufacturers to invest in medical devices. This has resulted in increased adoption of pelvic floor diagnostics along with the growth of other associated markets such to treat pelvic floor prolapse and other dysfunctions.
What Factors Drive Pelvic Floor Diagnostics Market?
The growth of the pelvic floor diagnostics market is primarily associated with the growing prevalence of pelvic floor disorders globally and rising healthcare expenditure. The developments of technologically advanced diagnostic systems along with government support has led to a surge in demand for reliable and extensive diagnostic systems.
Improvements in reimbursement structures has led manufacturers to invest in the pelvic floor diagnostic sector creating a conducive environment for growth through 2031.
What is the Impact of the COVID-19 Crisis on Pelvic Floor Diagnostics?
The pandemic has worsened patient waiting times across the world. Significant reduction in the physicians’ office and diagnostic center visits and the subsequent decline in the number of prescription and pre-prescribed medication is expected to hamper market growth during COVID-19 crisis.
The availability of the COVID-19 vaccine nation-wide and speedy vaccination programs are expected to aid market recovery in the coming years. New device launches are expected to hamper growth with short-term disruptions in the supply chain, delaying pipeline research and development and changing the priority of leading healthcare companies to combat the COVID-19 outbreak. Thus, the pandemic negatively impacted the growth of the pelvic floor diagnostics market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
How is the Pelvic Floor Diagnostics Market Faring in the U.S.?
The U.S. dominates the market for pelvic floor diagnostics and is expected to witness steady growth during the forecast period according to Future Market Insights. The analysis estimates that the U.S. will account for a market share of 81.5% in North America in 2021.
The growth of pelvic floor diagnostics market in the country is characterized by the rising prevalence rate of pelvic floor disorders among pregnant women and the subsequent rise in healthcare expenditure.
Why is the Demand for Pelvic Floor Diagnostics Increasing in the U.K.?
The U.K pelvic floor diagnostics market is expected to witness a CAGR of 5.8% over the forecast period. Government support and funding’s has promoted demand. Rapid increase in the geriatric population is a primary factor leading to an increase in pelvic floor disorders.
According to estimates conducted by the UNU (United Nations University), the percentage of geriatrics above 65 years of age is expected to rise up to 16% by 2050 from 7% in 2000. A study conducted in 2005 by the World Health Organization determined that one of the major factors leading to urinary incontinence in women is ageing, which will also support sales prospects.
What is the Outlook of the Brazil Pelvic Floor Diagnostics Market?
Brazil holds a current market share of 48.9% of the revenue generated in Latin America in 2020. According to the analysis by Future Market Insights, the country is expected to present highly lucrative growth with a CAGR of 5.5% over the forecast period.
Brazil is expected to support profitable growth due to the increasing prevalence of pelvic floor disorders such as overactive bladders and urinary incontinence among females. In Brazil, estimates of the prevalence of OAB range from 7.6% to 25% and the rise in government regulations for its treatment.
The use of diagnostic devices and in-clinic diagnostic procedures for pelvic floor diagnosis has seen a proportionate increase along with the rising adoption rates by high-income population groups. The demand for hospitals and diagnostic laboratories for pelvic floor diagnosis has led to growth in the country.
What are the Prospects of Pelvic floor Diagnostics in Mexico?
In 2020, Mexico accounted for over 38.4% of market share, in Latin America. The moderately steady growth in the country is influenced by the growing demand of various pelvic floor diagnostic testing services.
Pelvic floor diagnosis has been hindered by the topic being considered taboo. Increasing expenditure and growing awareness programs by the government to support the population has led to a rise in the demand of pelvic floor diagnostics in Mexico.
Category-wise Insights
Why are Ultrasound Systems Key to Revenue Generation?
The demand for ultrasound systems in the pelvic floor diagnostics market globally is supported by the demand for ultrasound systems over radiological methods. Ultrasound systems amount to the largest market share of 37.3% as of 2020 and are expected to grow over the forecast period at a CAGR of 5.7%.
The growing advancements in the ultrasound systems has triggered a renewed interest in diagnostic imaging in urogynecology and female urology.
What is the Contribution of Hospitals to Pelvic Floor Diagnostics Sales?
Based on the end-user, the hospitals segment depicts the highest market share of 64.2% in the year 2021, and is projected to grow at a CAGR of 5.5% over the forecast period.
The revenue growth of the hospital segment is projected to account for over US$ 2,002.0 Mn by the end of the forecast period. The growth is supported by improving health infrastructure, increasing number of experienced physicians, availability of advanced devices, and rising research and development (R&D) spending for medical devices.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
Key players operating in the pelvic floor diagnostics market are involved in innovative research and development activities for specialized and efficient diagnostic devices. Major companies also focus on strategic of mergers and acquisitions for geographical expansion and increased market footprint.
- For instance, in March 2021, HOYA Corporation (the parent company of Albyn Medical) signed a five-year contract for technical collaboration and supply of diagnostics ultrasound systems and ultrasound sensor with Hitachi.
- In June 2021, Neusoft Corporation revealed its portfolio of medical imaging for diagnosis including its NeuAngio 30F high speed floor-mounted DSA system.
- In April 2021, Analytica Ltd. entered a joint venture with Shijiazhuang Biosphere Pty Ltd. and Hebei Nacol Bio-Technology Co. Ltd. for the production and distribution of its Pericoach urinary incontinence device.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value and Volume in ‘000’ Units |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, U.K., Germany, France, Spain, Italy, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, Oceania, GCC Countries, South Africa, Turkey |
|
Key Segments Covered |
Product and End User |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Pelvic Floor Diagnostics Market by Category
By Product:
- Urodynamics Systems
- Uroflowmetry Devices
- Anal Manometry Systems
- Cystoscopes
- Ultrasound Systems
- Cart/Trolley Based
- Portable Bladder Ultrasound Systems
- EMG
By End User:
- Hospitals
- Diagnostic Imaging Centers
- Specialty Clinics
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Frequently Asked Questions
The global pelvic floor diagnostics market is expected to surpass US$ 1.8 Bn in 2021.
GlaxoSmithKline Plc, Sanofi, Johnson & Johnson, and Pfizer cumulatively account for 25-30% of the market.
The U.S., Canada, India, China, and Japan consistently reflect high demand for pelvic floor diagnostics services.
The U.S., Canada, India, China, and Japan are the leading service providers for pelvic floor diagnostics services.
Expansion of the global geriatric demographic, urinary incontinence among pregnant women, and awareness campaigns for treatment options are likely to drive growth.
The pelvic floor diagnostics market grew by 7.4% between 2020 and 2021.
The market rose at a 4.6% CAGR from 2016 to 2020
The market in North America is projected to rise at a 7.6% CAGR through 2031.
The Europe pelvic floor diagnostics market is set to rise at a 7.8% CAGR through the assessment period.
In 2020, Japan and South Korea accounted for share of 32% and 19% share respectively in East Asia region.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Outlook
4.1.3. Per Capita Healthcare Expenditure Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Prevalence of Pelvic Floor Disorders
4.2.2. Rise in Government Healthcare Awareness Programmes
4.2.3. Availability of Advanced Diagnostic Systems
4.2.4. Adoption of diagnostic procedures
4.2.5. Cost of procedures
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 Economic analysis
5.4. COVID19 and Impact Analysis
5.4.1. Revenue By Product
5.4.2. Revenue By End User
5.4.3. Revenue By Region
5.5. 2020 Market Scenario
5.6. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Key Success Factors
6.1. Key Epidemiology, by Region
6.2. Product Adoption Rate, By Region
6.3. Product Approval and Launches
6.4. Regulatory Scenario
6.5. Reimbursement Scenario
7. Global Pelvic Floor Diagnostics Market Demand Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Volume (‘000’ Units) Analysis, 2016-2020
7.2. Current and Future Market Volume (‘000’ Units) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Pelvic Floor Diagnostics Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Global Average Pricing Analysis
9. Global Pelvic Floor Diagnostics Market Value (in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) and Volume (‘000’ Units) Analysis By Product, 2016–2020
10.3. Current and Future Market Value (US$ Mn) and Volume (‘000’ Units) Analysis and Forecast By Product, 2021-2031
10.3.1. Urodynamics Systems
10.3.2. Uroflowmetry Devices
10.3.3. Anal Manometry Systems
10.3.4. Cystoscopes
10.3.5. Ultrasound Systems
10.3.5.1. Cart/Trolley Based
10.3.5.2. Portable Bladder Ultrasound Systems
10.3.6. EMG
10.4. Market Attractiveness Analysis By Product
11. Global Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Value (US$ Mn) Analysis By End User, 2016–2020
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2021-2031
11.3.1. Hospitals
11.3.2. Diagnostic Centres
11.3.3. Specialized Clinics
11.4. Market Attractiveness Analysis By End User
12. Global Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By Region
12.1. Introduction / Key Findings
12.2. Historical Market Value (US$ Mn) and Volume (‘000’ Units) Analysis By Region, 2016–2020
12.3. Current and Future Market Value (US$ Mn) and Volume (‘000’ Units) Analysis and Forecast By Region, 2021-2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. North America Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016–2020
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016–2020
14.3. Current and Future Market Size (US$ Mn) Trend and Analysis and Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016–2020
15.3. Current and Future Market Size (US$ Mn) Trend and Analysis and Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016–2020
16.3. Current and Future Market Size (US$ Mn) Trend and Analysis and Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016–2020
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016–2020
18.3. Current and Future Market Size (US$ Mn) Trend and Analysis and Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Pelvic Floor Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016–2020
19.3. Current and Future Market Size (US$ Mn) Trend and Analysis and Forecast By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Key Countries Pelvic Floor Diagnostics Market Analysis 2021 & 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. U.S. Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.2.1. By Product
20.2.2. By End User
20.3. Canada Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.3.1. By Product
20.3.2. By End User
20.4. Mexico Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.4.1. By Product
20.4.2. By End User
20.5. Brazil Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.5.1. By Product
20.5.2. By End User
20.6. U.K. Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.6.1. By Product
20.6.2. By End User
20.7. Germany Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.7.1. By Product
20.7.2. By End User
20.8. France Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.8.1. By Product
20.8.2. By End User
20.9. Italy Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.9.1. By Product
20.9.2. By End User
20.10. Spain Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.10.1. By Product
20.10.2. By End User
20.11. BENELUX Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.11.1. By Product
20.11.2. By End User
20.12. Russia Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.12.1. By Product
20.12.2. By End User
20.13. China Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.13.1. By Product
20.13.2. By End User
20.14. Japan Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.14.1. By Product
20.14.2. By End User
20.15. South Korea Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.15.1. By Product
20.15.2. By End User
20.16. India Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.16.1. By Product
20.16.2. By End User
20.17. Thailand Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.17.1. By Product
20.17.2. By End User
20.18. Malaysia Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.18.1. By Product
20.18.2. By End User
20.19. Indonesia Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.19.1. By Product
20.19.2. By End User
20.20. Australia Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.20.1. By Product
20.20.2. By End User
20.21. New Zealand Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.21.1. By Product
20.21.2. By End User
20.22. GCC Countries Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.22.1. By Product
20.22.2. By End User
20.23. Turkey Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.23.1. By Product
20.23.2. By End User
20.24. South Africa Pelvic Floor Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.24.1. By Product
20.24.2. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Concentration
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Deep Dive
22.2.1. Laborie, Inc.
22.2.1.1. Overview
22.2.1.2. Service Portfolio
22.2.1.3. Company Footprint
22.2.1.4. Strategy Overview
22.2.2. Cooper Surgical
22.2.2.1. Overview
22.2.2.2. Service Portfolio
22.2.2.3. Company Footprint
22.2.2.4. Strategy Overview
22.2.3. SRS Medical
22.2.3.1. Overview
22.2.3.2. Service Portfolio
22.2.3.3. Company Footprint
22.2.3.4. Strategy Overview
22.2.4. Medtronic Plc.
22.2.4.1. Overview
22.2.4.2. Service Portfolio
22.2.4.3. Company Footprint
22.2.4.4. Strategy Overview
22.2.5. MEDSPIRA
22.2.5.1. Overview
22.2.5.2. Service Portfolio
22.2.5.3. Company Footprint
22.2.5.4. Strategy Overview
22.2.6. MEDKONSULT medical technology s.r.o.
22.2.6.1. Overview
22.2.6.2. Service Portfolio
22.2.6.3. Company Footprint
22.2.6.4. Strategy Overview
22.2.7. Albyn Medical
22.2.7.1. Overview
22.2.7.2. Service Portfolio
22.2.7.3. Company Footprint
22.2.7.4. Strategy Overview
22.2.8. PENTAX Medical
22.2.8.1. Overview
22.2.8.2. Service Portfolio
22.2.8.3. Company Footprint
22.2.8.4. Strategy Overview
22.2.9. Olympus Medical Systems
22.2.9.1. Overview
22.2.9.2. Service Portfolio
22.2.9.3. Company Footprint
22.2.9.4. Strategy Overview
22.2.10. Stryker's
22.2.10.1. Overview
22.2.10.2. Service Portfolio
22.2.10.3. Company Footprint
22.2.10.4. Strategy Overview
22.2.11. EndoMed Systems
22.2.11.1. Overview
22.2.11.2. Service Portfolio
22.2.11.3. Company Footprint
22.2.11.4. Strategy Overview
22.2.12. Richard Wolf
22.2.12.1. Overview
22.2.12.2. Service Portfolio
22.2.12.3. Company Footprint
22.2.12.4. Strategy Overview
22.2.13. Schölly Fiberoptic
22.2.13.1. Overview
22.2.13.2. Service Portfolio
22.2.13.3. Company Footprint
22.2.13.4. Strategy Overview
22.2.14. Zhuhai Seesheen Medical Technology
22.2.14.1. Overview
22.2.14.2. Service Portfolio
22.2.14.3. Company Footprint
22.2.14.4. Strategy Overview
22.2.15. KARL STORZ
22.2.15.1. Overview
22.2.15.2. Service Portfolio
22.2.15.3. Company Footprint
22.2.15.4. Strategy Overview
22.2.16. Cadwell
22.2.16.1. Overview
22.2.16.2. Service Portfolio
22.2.16.3. Company Footprint
22.2.16.4. Strategy Overview
22.2.17. The Prometheus Group
22.2.17.1. Overview
22.2.17.2. Service Portfolio
22.2.17.3. Company Footprint
22.2.17.4. Strategy Overview
22.2.18. Neurosoft
22.2.18.1. Overview
22.2.18.2. Service Portfolio
22.2.18.3. Company Footprint
22.2.18.4. Strategy Overview
22.2.19. Noraxon USA
22.2.19.1. Overview
22.2.19.2. Service Portfolio
22.2.19.3. Company Footprint
22.2.19.4. Strategy Overview
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 02: Global Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 03: Global Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 04: Global Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region
Table 05: Global Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region
Table 06: North America Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 07: North America Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 08: North America Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 09: North America Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User
Table 10: Latin America Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 11: Latin America Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 12: Latin America Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 13: Latin America Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 14: Europe Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 15: Europe Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 16: Europe Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 17: Europe Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 18: East Asia Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 19: East Asia Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 20: East Asia Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 21: East Asia Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 22: South Asia Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 23: South Asia Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 24: South Asia Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 25: South Asia Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 26: Middle East & Africa Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 27: Oceania Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 28: Oceania Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 29: Oceania Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 30: Oceania Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 31: Middle East & Africa Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 32: Middle East & Africa Pelvic Floor Diagnostic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 33: Middle East & Africa Pelvic Floor Diagnostic Market Volume (‘000’ Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Pelvic Floor Diagnostic Market Historical Market Volume (‘000’ Units) Analysis, 2016-2020
Figure 02: Global Pelvic Floor Diagnostic Market Volume (‘000’ Units), 2021-2031 & Y-o-Y Growth Trend Analysis
Figure 03: Urodynamics Systems Pricing Analysis (US$) Per Device, By Region, 2020
Figure 04: Uroflowmetry Devices Pricing Analysis (US$) Per Device, By Region, 2020
Figure 05: Anal Manometry Systems Pricing Analysis (US$) Per Device, By Region, 2020
Figure 06: Cystoscopes Pricing Analysis (US$) Per Device, By Region, 2020
Figure 07: Cart/Trolley Based Ultrasound Systems Pricing Analysis (US$) Per Device, By Region, 2020
Figure 08: Portable Bladder Ultrasound Systems Pricing Analysis (US$) Per Device, By Region, 2020
Figure 09: EMG Pricing Analysis (US$) Per Device, By Region, 2020
Figure 10: Global Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 11: Global Pelvic Floor Diagnostic Market Value (US$ Mn) Forecast, 2021 - 2031
Figure 12: Global Pelvic Floor Diagnostic Market Absolute $ Opportunity, 2021 - 2031
Figure 13: Global Pelvic Floor Diagnostic Market Share Analysis (%), By Product, 2021& 2031
Figure 14: Global Pelvic Floor Diagnostic Market Y-o-Y Analysis (%), By Product, 2021- 2031
Figure 15: Global Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021 - 2031
Figure 16: Global Pelvic Floor Diagnostic Market Share Analysis (%), By End User, 2021& 2031
Figure 17: Global Pelvic Floor Diagnostic Market Y-o-Y Analysis (%), By End User, 2021 - 2031
Figure 18: Global Pelvic Floor Diagnostic Market Attractiveness Analysis By End User, 2021& 2031
Figure 19: Global Pelvic Floor Diagnostic Market Share Analysis (%), By Country, 2021& 2031
Figure 20: Global Pelvic Floor Diagnostic Market Y-o-Y Analysis (%), By Country, 2021& 2031
Figure 21: Global Pelvic Floor Diagnostic Market Attractiveness Analysis by Country, 2021- 2031
Figure 22: North America Pelvic Floor Diagnostic Market Value Share By Product 2021 (E)
Figure 23: North America Pelvic Floor Diagnostic Market Value Share By End User 2021 (E)
Figure 24: North America Pelvic Floor Diagnostic Market Value Share By Country 2021 (E)
Figure 25: North America Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 26: North America Pelvic Floor Diagnostic Market Value Forecast (US$ Mn), 2021- 2031
Figure 27: North America Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021 -2031
Figure 28: North America Pelvic Floor Diagnostic Market Attractiveness Analysis By End User, 2021 - 2031
Figure 29: North America Pelvic Floor Diagnostic Market Attractiveness Analysis By Country, 2021 - 2031
Figure 30: Latin America Pelvic Floor Diagnostic Market Value Share By Product 2021 (E)
Figure 31: Latin America Pelvic Floor Diagnostic Market Share By End User 2021 (E)
Figure 32: Latin America Pelvic Floor Diagnostic Market Value Share By Country 2021 (E)
Figure 33: Latin America Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 34: Latin America Pelvic Floor Diagnostic Market Value Forecast (US$ Mn), 2021 & 2031
Figure 35: Latin America Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021 - 2031
Figure 36: Latin America Pelvic Floor Diagnostic Market Attractiveness Analysis By End User, 2021 - 2031
Figure 37: Latin America Pelvic Floor Diagnostic Market Attractiveness Analysis By Country, 2021 - 2031
Figure 38: Europe Pelvic Floor Diagnostic Market Value Share, By Product 2021 (E)
Figure 39: Europe Pelvic Floor Diagnostic Market Value Share By End User 2021 (E)
Figure 40: Europe Pelvic Floor Diagnostic Market Value Share By Country 2021 (E)
Figure 41: Europe Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 42: Europe Pelvic Floor Diagnostic Market Value Forecast (US$ Mn), 2021 - 2031
Figure 43: Europe Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021 - 2031
Figure 44: Europe Pelvic Floor Diagnostic Market Attractiveness Analysis By End User, 2021 - 2031
Figure 45: Europe Pelvic Floor Diagnostic Market Attractiveness Analysis By Country, 2021 - 2031
Figure 46: East Asia Pelvic Floor Diagnostic Market Value Share, By Product 2021 (E)
Figure 47: East Asia Pelvic Floor Diagnostic Market Value Share, By End User 2021 (E)
Figure 48: East Asia Pelvic Floor Diagnostic Market Value Share, By Country 2021 (E)
Figure 49: East Asia Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 50: East Asia Pelvic Floor Diagnostic Market Value Forecast (US$ Mn), 2021 -2031
Figure 51: East Asia Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021-2031
Figure 52: East Asia Pelvic Floor Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 53: East Asia Pelvic Floor Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 54: South Asia Pelvic Floor Diagnostic Market Value Share By Product 2021 (E)
Figure 55: South Asia Pelvic Floor Diagnostic Market Value Share By End User 2021 (E)
Figure 56: South Asia Pelvic Floor Diagnostic Market Value Share By Country 2021 (E)
Figure 57: South Asia Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 58: South Asia Pelvic Floor Diagnostic Market Value Forecast (US$ Mn), 2021 - 2031
Figure 59: South Asia Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021-2031
Figure 60: South Asia Pelvic Floor Diagnostic Market Attractiveness Analysis By End User, 2021-2031
Figure 61: South Asia Pelvic Floor Diagnostic Market Attractiveness Analysis By Country, 2021-2031
Figure 62: Oceania Pelvic Floor Diagnostic Market Value Share By Product 2021 (E)
Figure 63: Oceania Pelvic Floor Diagnostic Market Value Share By End User 2021 (E)
Figure 64: Oceania Pelvic Floor Diagnostic Market Value Share By Country 2021 (E)
Figure 65: Oceania Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 66: Oceania Pelvic Floor Diagnostic Market Value Forecast (US$ Mn), 2021& 2031
Figure 67: Oceania Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021-2031
Figure 68: Oceania Pelvic Floor Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 69: Oceania Pelvic Floor Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 70: Middle East & Africa Pelvic Floor Diagnostic Market Value Share By Product 2021 (E)
Figure 71: Middle East & Africa Pelvic Floor Diagnostic Market Value Share By End User 2021 (E)
Figure 72: Middle East & Africa Pelvic Floor Diagnostic Market Value Share By Country 2021 (E)
Figure 73: Middle East & Africa Pelvic Floor Diagnostic Market Value Analysis (US$ Mn), 2016-2020
Figure 74: Middle East & Africa Pelvic Floor Diagnostic Market Value Forecast (US$ Mn), 2021-2031
Figure 75: Middle East & Africa Pelvic Floor Diagnostic Market Attractiveness Analysis By Product, 2021-2031
Figure 76: Middle East & Africa Pelvic Floor Diagnostic Market Attractiveness Analysis By End User, 2021-2031
Figure 77: Middle East & Africa Pelvic Floor Diagnostic Market Attractiveness Analysis By Country, 2021-2031
Figure 78: Global Pelvic Floor Diagnostic Market Value Proportion Analysis, By Key Countries, 2021 (E)
Figure 79: Pelvic Floor Diagnostic Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2021-2031
Figure 80: U.S. Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 81: U.S. Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 82: Global Vs U.S. Growth Comparison
Figure 83: Canada Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 84: Canada Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 85: Global Vs Canada Growth Comparison
Figure 86: Mexico Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 87: Mexico Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 88: Global Vs Mexico Growth Comparison
Figure 89: Brazil Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 90: Brazil Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 91: Global Vs Brazil Growth Comparison
Figure 92: U.K. Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 92: U.K. Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 94: Global Vs U.K. Growth Comparison
Figure 95: Germany Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 96: Germany Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 97: Global Vs Germany Growth Comparison
Figure 98: France Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 99: France Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 100: Global Vs France Growth Comparison
Figure 101: Italy Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 102: Italy Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 103: Global Vs Italy Growth Comparison
Figure 104: Spain Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 105: Spain Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 106: Global Vs Spain Growth Comparison
Figure 107: BENELUX Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 108: BENELUX Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 109: Global Vs BENELUX Growth Comparison
Figure 110: Russia Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 111: Russia Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 112: Global Vs Russia Growth Comparison
Figure 113: China Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 114: China Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 115: Global Vs China Growth Comparison
Figure 116: Japan Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 117: Japan Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 118: Global Vs Japan Growth Comparison
Figure 119: South Korea Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 120: South Korea Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 121: Global Vs South Korea Growth Comparison
Figure 122: India Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 123: India Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 124: Global Vs India Growth Comparison
Figure 125: Thailand Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 126: Thailand Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 127: Global Vs Thailand Growth Comparison
Figure 128: Malaysia Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 129: Malaysia Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 130: Global Vs Malaysia Growth Comparison
Figure 131: Indonesia Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 132: Indonesia Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 133: Global Vs Indonesia Growth Comparison
Figure 134: Australia Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 135: Australia Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 136: Global Vs Australia Growth Comparison
Figure 137: New Zealand Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 138: New Zealand Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 139: Global Vs New Zealand Growth Comparison
Figure 140: GCC Countries Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 141: GCC Countries Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 142: Global Vs GCC Countries Growth Comparison
Figure 143: Turkey Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 144: Turkey Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 145: Global Vs Turkey Growth Comparison
Figure 146: South Africa Pelvic Floor Diagnostic Market Share Analysis, By Product, 2021 & 2031
Figure 147: South Africa Pelvic Floor Diagnostic Market Share Analysis, By End User, 2021 & 2031
Figure 148: Global Vs South Africa Growth Comparison
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
